1. How has Merck been able to achieve substantial returns to capital given the large costs and lengthy time to develop drugs? Merck had a 14% increase in sales between 1997 and 1998 and 22% increase in sales from 1998 – 1999‚ and a 13% annual increase in earnings over the same period. Merck’s business strategy consists of two parts: (1) developing and marketing new drugs through internal research‚ and (2) developing partnerships with smaller biotechnology companies. Since 1995‚ Merck had launched
Premium Expected value License Money
Pharmaceuticals: Merck Sustaining Long-term Advantage Through Information Technology Hiroshi Amari Working Paper No. 161 Working Paper Series Center on Japanese Economy and Business Columbia Business School December 1998 Columbia-Yale Project: Use of Software to Achieve Competitive Advantage PHARMACEUTICALS: MERCK Sustaining Long-term Advantage Through Information Technology Prepared by Hiroshi Amari Research Associate‚ Yale University William V. Rapp and Hugh T. Patrick Co-principal
Premium Clinical trial Pharmaceutical industry Drug development
heart attacks f) Merck blamed naproxen for skewing the results against Vioxx 3) New England Journal of Medicine Omission g) Merck omits three heart attacks from article submission h) Inclusion of omitted data caused a significantly greater result 4) FDA Reaction i) Letter regarding downplay of risks j) Addition of warning label to Vioxx k) Additional study results 5) Approve Study l) Results with placebo group cause Merck to recall drug
Premium Coronary artery disease Aspirin Hypertension
Pocknee and Taylor’s (1996)‚ explains the strategy making process via ESC model. Fig 1.1 shows the ESC (Environment‚ Strategy & Capabilities) model to describe the strategy making process for an organization. Strategies are made keeping a number of factors in consideration. Environment stands for Macro and industry based environment and factors that effect the operation of an organization. Environment is discussed more in detail in later part of this report. Business strategies are made considering
Premium Strategic management Starbucks Porter five forces analysis
External Analysis 1. PESTLE Factors Political and Legal· Government has high work efficiency‚ justice and transparency.· Company or individual have low tax rate easy to calculate.· Government supports the development of industry and commerce. | Economic·Hong Kong is the world’s 11th trading powers and 2nd stock market in Asia.·One of the most free trade port and open investment policy. It is the only one RMB offshore market.·Over-estimation of the number of visitors.·Loss $46 million in the
Premium China Mainland China People's Republic of China
LVMH – Fashion & Leather Goods External Analysis Faurum Doshi LVMH Summary LVMH‚ known as Moët Hennessy • Louis Vuitton‚ is a French conglomerate and the largest producer of luxury goods in the world. LVMH was formed in 1987 with the merger of Moet et Chandon a champagne manufacturer‚ Hennessy a cognac manufacturer‚ and Louis Vuitton a fashion house. The LVMH group is comprised over five sectors: Fashion & Leather Goods‚ Wine & Spirits‚ Perfumes & Cosmetics‚ Watches &
Premium LVMH Luxury good Gucci
Merck and Company‚ Inc.: SWOT Analysis and Stakeholder Evaluation Merck and Company‚ Inc.‚ a.k.a. Merck‚ is a leading worldwide pharmaceutical company that engages in manufacturing and marketing medicines‚ animal products‚ vaccines‚ and consumer health products. As most companies‚ Merck desires to continue their success as one of the top health care innovators in the world. Conducting a SWOT analysis can give them insight into internal strengths and weaknesses as well as external opportunities
Premium Pharmaceutical industry Marketing
including Bayer AG and Novartis are exploring a deal for Merck & Co Inc’s consumer healthcare business‚ as they seek to gain scale in a fragmented industry‚ according to several people familiar with the matter. Reckitt Benckiser Group PLC and Procter & Gamble Co are also among the parties that have held discussions with Merck about buying the unit‚ best known for Coppertone sunscreen and Claritin allergy medicine‚ the sources said this week. The Merck business‚ which also includes Dr. Scholl’s foot
Premium Pharmacology Marketing Pharmacy
TO: Dr. Roy Vagelos‚ Chairman and CEO Merck Corporation. January‚ 1991. The decision to move forward with the program to donate the new drug Mectizan on a large scale to the affected population in the Third World needs to be systematically analyzed. There are two especially important angles from which this decision needs to be considered. The first concern that needs to be taken into account is that of the stockholders and investors in this company‚ whose interests you are ultimately charged with
Premium Medicine Pharmacology Pharmacy
SESSION 2: EXTERNAL ANALYSIS AND MBV Market Based View of Strategy: External environment analysis > strategic issues-> winning strategies-> superior performance Market based view of strategy (MBV) - sometimes known as Industrial Organisation based view (IO) places primary importance on external conditions faced by the firm. In this view‚ strategy is about the firm creating for itself a ‘market position’ via strategy whereby it can defend itself from external environmental forces and/or
Premium Strategic management Barriers to entry Management